Many post-authorisation studies fail to comply with public disclosure rules
Better adherence is required for greater research transparency, say researchers Many post-authorisation studies registered with the European Medicines Agency (EMA) fail to comply with legal requirements and recommendations to make their findings public, finds a study published by The BMJ today. Post-authorisation studies (PAS) are carried out after a medicine is approved ...

